Sharp Rees-Stealy Medical Group is a leading health care provider in San Diego that offered Glooko to a population of type 2 patients, with the goal of increasing patient engagement and improving outcomes.  Patients using Glooko doubled their blood glucose testing frequency and improved their average blood glucose levels by ~15 mg/dL, which translates to a 0.9 point improvement in estimated A1c.  Due to these strong outcomes, Sharp Rees-Stealy is expanding its rollout of Glooko to a larger patient population.  Learn more about Sharp Rees-Stealy’s Glooko program by downloading the case study.